TrialAnnals of epidemiology2026

Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation.

Amy Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.